JEFFREY L WADE
CIK 1225767 · President and COO · last filed 2024-07-08
JEFFREY L WADE is a President and COO who has filed 39 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for LXRX, was dated Jul 8, 2024. Across all open-market trades the lifetime net is +$60.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $600.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$600.6K
2
39
$60.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | President and COO | 312,792 | $1.92 | $600.6K | $60.8K | 38 | 2024-07-08 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Gen. Counsel | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-08 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-29 | LXRX | Mixed | +59,873 | -$98.8K | EDGAR |
| 2024-02-12 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2023-09-14 | LXRX | Buy (P) | +10,000 | $13.8K | EDGAR |
| 2023-06-20 | LXRX | Buy (P) | +12,000 | $28.0K | EDGAR |
| 2023-03-01 | LXRX | Mixed | +48,661 | -$65.7K | EDGAR |
| 2023-02-13 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | LXRX | Mixed | +41,160 | -$73.5K | EDGAR |
| 2022-02-14 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2021-03-02 | LXRX | Mixed | +41,525 | -$191.1K | EDGAR |